From: www.ecancer.tv on Fri, Dec 03 2010 5:22 AM

Dr Andras Fehervary offers the industry perspective on the barriers that are preventing patients joining clinical trials and explains how they are working to remove these barriers. The barriers include regulatory issues, industry economics, geographical infrastructure and educational issues. Dr ...

From: www.ecancer.tv on Thu, Nov 25 2010 10:57 AM

Prof Tim Illidge speaks to ecancer.tv about the opening of the new patient treatment centre at The Christie NHS Foundation Trust in Manchester. This centre will allow The Christie Trust to further improve the level of service it offers to the patients within its considerable catchment area. Prof ...

From: www.ecancer.tv on Thu, Nov 25 2010 10:56 AM

Helen Ferns speaks about the new patient treatment centre opening as part of the Christie NHS Foundation Trust in Manchester. This unit will be the largest early clinical trials unit in the world, the largest chemotherapy facility in the UK (increasing treatments from 30,000 to 38,000 a year) an...

From: www.ecancer.tv on Wed, Nov 24 2010 9:44 AM

Prof Alberto Sobrero speaks about some key clinical studies on colorectal cancer which were presented at ESMO 2010. Two of these trials looked at cediranib, an inhibitor of VEGF receptor tyrosine kinase, however these large scale trials did not show superiority. A separate trial involving just 2...

From: www.ecancer.tv on Tue, Nov 23 2010 2:25 PM

Prof Annamaria Colao speaks to ecancertv about Cushing’s disease; the causes of the disease, who is most susceptible and the difficulties of diagnosis. Cushing's disease is very severe and associated with a 50% mortality within five years. The only approved treatment is surgery followed by ...

From: www.ecancer.tv on Tue, Nov 23 2010 2:25 PM

Prof Annamaria Colao explains the causes and effects of acromegaly and discusses a number of trials comparing the efficacy of current therapies, investigating new first line treatments and treatments for resistant patients. Prof Colao talks about hyperparathyroidism, outlining research into cina...

From: www.ecancer.tv on Tue, Nov 23 2010 2:25 PM

Dr Alberto Pedroncelli speaks about two clinical trials, one to compare pasireotide with octreotide in medically naïve acromegaly patients and one to compare pasireotide with octreotide or lanreotide in inadequately controlled patients. It is hoped that these studies will establish pasireotide a...

From: www.ecancer.tv on Wed, Nov 17 2010 10:42 AM

www.ecancer.tv

From: www.ecancer.tv on Wed, Nov 17 2010 10:42 AM

MEP Nessa Childers speaking at the Forum Against Cancer Europe (FACE) 'Cross Border Healthcare' meeting on the 15th September 2010. Organised by the European Cancer Patient Coalition.The problems of cross-border healthcare. Denmark setting the example of generous cancer care.

From: www.ecancer.tv on Wed, Nov 10 2010 8:06 AM

Dr Nicola Fazio speaks about the different types of neuroendocrine tumours and the results of the Radiant-2 and Radiant 3 trials which were presented at ESMO 2010. Radiant 2 compared everolimus and octreotide long-acting release (LAR) with placebo and octreotide LAR in patients with advanced neur...

From: www.ecancer.tv on Wed, Nov 10 2010 8:06 AM

Prof Jonathan Ledermann talks about the possibility of using bevacizumab in the first line treatment of ovarian cancer. Research presented at ESMO 2010 in addition to previous research presented at ASCO 2010 demonstrated that the addition of bevacizumab to standard chemotherapy prolongs progressi...

From: www.ecancer.tv on Wed, Nov 10 2010 8:06 AM

Prof Dorothy Keefe talks about three posters presented at the 2010 ESMO meeting in Milan. Two of these posters addressed pain management; one investigating the use of a nasal spray to administer pain killers to patients who have trouble swallowing pills, and the second tried to identify the opti...

From: www.ecancer.tv on Wed, Nov 10 2010 8:06 AM

Dr Johann de Bono speaks to ecancer.tv about PARP inhibitors, the benefits that these drugs have shown and what still needs to be done before they can be approved. Dr de Bono suggests how modifying the way patients are selected could speed up drug approval and discusses what challenges must be o...

From: www.ecancer.tv on Wed, Nov 10 2010 7:00 AM

Prof Bernard Escudier of the Institut Gustave Roussy, Paris, talks to ecancer at ESMO 2010 about his work with reducing unnecessary treatment for renal cancer and improved targeting of treatment.

From: www.ecancer.tv on Wed, Nov 10 2010 7:00 AM

Prof Francesco De Lorenzo speaks about an Italian multimedia service that aims to help recovering cancer patients return to work and regain a normal social life.This service provides information relating to a range of issues including psychological and social rehabilitation, how to apply for ben...

From: www.ecancer.tv on Wed, Nov 10 2010 5:56 AM

Dr Claudio Lombardo talks about the importance of effectively disseminating the goals, objectives and activities of OECI and how the new partnership with ecancer.tv will benefit information distribution. Dr Lombardo discusses the main working groups that OECI acts through, the support it is avai...

From: www.ecancer.tv on Wed, Nov 10 2010 5:56 AM

Dr James Mackay speaks about the increased requirement for genetic testing within oncology. There is currently an unacceptable level of variation in the turnaround times for these tests and this variation must be addressed before patients can receive equal treatment opportunities irrespective of ...

From: www.ecancer.tv on Thu, Nov 04 2010 3:19 PM

Prof Kjell Öberg discusses the development of new biomarkers which allow early detection of pNET and identify patients who are at high risk of recurrence after surgery and speaks about the superiority of molecular imaging with PET scan over traditional imaging technologies. Prof Öberg explains ho...

From: www.ecancer.tv on Thu, Nov 04 2010 3:19 PM

Dr Chris Harrison explains how being part of OECI allows the Christie Centre to compare the service it offers with other institutes across Europe, to combine its resources and conduct research in collaboration with many of the most technically advanced cancer centres in Europe.

From: www.ecancer.tv on Thu, Nov 04 2010 3:19 PM

Dr Mahasti Saghatchian talks about the OECI accreditation process which aims to provide a consistent set of good practice standards for patient care and research within the European cancer community in addition to offering recognition for cancer centres that perform well. Dr Saghatchian explains ...